Opportunity Information: Apply for RFA CA 23 022
The National Cancer Institute (NCI), under the National Institutes of Health (NIH), released this funding opportunity to create and operate a Coordinating and Communication Center for the Cancer Screening Research Network (CSRN). This award uses a cooperative agreement mechanism (UG1), which generally means NCI will have substantial scientific and programmatic involvement in how the work is planned and carried out, rather than functioning as a hands-off funder. The Coordinating and Communication Center is one of three related funding announcements meant to stand up the infrastructure for a national network capable of designing and running multi-center cancer screening clinical trials and other large screening studies.
The bigger purpose of the CSRN is to make it easier to conduct rigorous, real-world cancer screening research across many healthcare systems and settings, using large and diverse patient populations who are already receiving routine care. Through these trials and studies, the network aims to improve early cancer detection, carefully evaluate new and emerging screening approaches or modalities, and ultimately contribute to reductions in cancer incidence as well as cancer-related illness and death. The emphasis is on multi-site work at scale, reflecting an intent to generate evidence that is both scientifically strong and broadly applicable to different communities and care environments.
As the Coordinating and Communication Center, the funded organization would be expected to provide the backbone functions that allow a national screening network to operate smoothly. While the notice highlights the overall infrastructure goal rather than listing every task in the excerpt provided, centers like this typically handle cross-site coordination, communication structures, operational consistency, and network-level support that helps multiple clinical sites run complex screening trials in a harmonized way. In practice, this kind of hub commonly supports study start-up and management across sites, facilitates network communications and stakeholder engagement, helps standardize procedures and reporting, and supports collaboration so that trials and studies can be executed efficiently and consistently across participating healthcare settings.
Eligibility is broad and includes many types of U.S.-based organizations and government entities. Eligible applicants include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; Native American tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofits with and without 501(c)(3) status (excluding higher education institutions in those nonprofit categories); for-profit organizations other than small businesses; and small businesses. The FOA also explicitly calls out additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, Indian/Native American tribal governments other than federally recognized, and U.S. territories or possessions.
At the same time, the opportunity draws clear boundaries around foreign participation. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply. In addition, non-domestic components of U.S. organizations are not eligible, and foreign components as defined by the NIH Grants Policy Statement are not allowed. These restrictions signal that the network infrastructure and the funded coordinating functions are intended to be built and operated entirely within allowable U.S. organizational structures.
Key administrative details from the source data include the Funding Opportunity Title "NCI Cancer Screening Research Network: Coordinating and Communication Center (UG1 Clinical Trial Required)," with Funding Opportunity Number RFA-CA-23-022. It is categorized as a discretionary opportunity and uses the cooperative agreement funding instrument type. The activity category is listed under education and health, and the CFDA numbers associated with the program are 93.393, 93.394, and 93.399. The opportunity was created on 2022-11-17, and the original closing date was 2023-02-28. The excerpt provided does not list an award ceiling or expected number of awards, indicating those fields were either not specified in the supplied source data or were not populated there.Apply for RFA CA 23 022
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "NCI Cancer Screening Research Network: Coordinating and Communication Center (UG1 Clinical Trial Required)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393, 93.394, 93.399.
- This funding opportunity was created on 2022-11-17.
- Applicants must submit their applications by 2023-02-28. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Education, Health
Next opportunity: Cooperative Development Program_APS
Previous opportunity: John Lewis NIMHD Research Endowment Program (S21 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CA 23 022
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CA 23 022) also looked into and applied for these:
| Funding Opportunity |
|---|
| Mechanistic links between diet, lipid metabolism, and tumor growth and progression (UH2 Clinical Trial Not Allowed) Apply for PAR 23 052 Funding Number: PAR 23 052 Agency: National Institutes of Health Category: Education, Health Funding Amount: $275,000 |
| Mechanistic links between diet, lipid metabolism, and tumor growth and progression (U01 Clinical Trial Not Allowed) Apply for PAR 23 051 Funding Number: PAR 23 051 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) Apply for RFA CA 23 004 Funding Number: RFA CA 23 004 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) Apply for RFA CA 23 003 Funding Number: RFA CA 23 003 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) Apply for RFA CA 23 005 Funding Number: RFA CA 23 005 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) Apply for RFA CA 23 009 Funding Number: RFA CA 23 009 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional) Apply for RFA CA 23 008 Funding Number: RFA CA 23 008 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) Apply for RFA CA 23 007 Funding Number: RFA CA 23 007 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) Apply for RFA CA 23 010 Funding Number: RFA CA 23 010 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) Apply for RFA CA 23 002 Funding Number: RFA CA 23 002 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) Apply for RFA CA 23 006 Funding Number: RFA CA 23 006 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional) Apply for RFA CA 23 011 Funding Number: RFA CA 23 011 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NCI Small Grants Program for Cancer Research for Years 2023, 2024, and 2025 (NCI Omnibus) (R03 Clinical Trial Optional) Apply for PAR 23 058 Funding Number: PAR 23 058 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Rapid Translation of Epidemiological Findings into Interventions to Prevent Substance Use and Addiction (R61/R33 Clinical Trial Optional) Apply for RFA DA 24 010 Funding Number: RFA DA 24 010 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| National Cancer Institute Program Project Applications for the Years 2023, 2024, and 2025 (P01 Clinical Trial Optional) Apply for PAR 23 059 Funding Number: PAR 23 059 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Co-infection and Cancer (R01 Clinical Trial Not Allowed) Apply for PAR 23 055 Funding Number: PAR 23 055 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Co-infection and Cancer (R21 Clinical Trial Not Allowed) Apply for PAR 23 056 Funding Number: PAR 23 056 Agency: National Institutes of Health Category: Education, Health Funding Amount: $275,000 |
| Mechanisms and Targets at the Intersection of HIV and Substance Use (R21 Clinical Trials Not Allowed) Apply for RFA DA 24 014 Funding Number: RFA DA 24 014 Agency: National Institutes of Health Category: Education, Health Funding Amount: $275,000 |
| Mechanisms and Targets at the Intersection of HIV and Substance Use (R01 Clinical Trials Not Allowed) Apply for RFA DA 24 013 Funding Number: RFA DA 24 013 Agency: National Institutes of Health Category: Education, Health Funding Amount: $400,000 |
| Substance Use Prevention Effectiveness Research Among Youth and Families in the Child Welfare System (R61/R33 Clinical Trial Required) Apply for RFA DA 24 011 Funding Number: RFA DA 24 011 Agency: National Institutes of Health Category: Education, Health Funding Amount: $600,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 23 022", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
